Results 131 to 140 of about 43,050 (216)

Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients. [PDF]

Genome Med, 2022
Grimaldi A, Panariello F, Annunziata P, Giuliano T, Daniele M, Pierri B, Colantuono C, Salvi M, Bouché V, Manfredi A, Cuomo MC, Di Concilio D, Tiberio C, Fiorenza M, Portella G, Cimmino I, Sorrentino A, Fusco G, Granata MR, Cerino P, Limone A, Atripaldi L, Ballabio A, Cacchiarelli D.   +23 more
europepmc   +1 more source

Tracking the Spread of the BA.2.86 Lineage in Italy Through Wastewater Analysis. [PDF]

Food Environ Virol
Veneri C, Brandtner D, Mancini P, Bonanno Ferraro G, Iaconelli M, Suffredini E, Petrillo M, Leoni G, Paracchini V, Gawlik BM, Marchini A, SARI Network, La Rosa G.   +12 more
europepmc   +1 more source

Evidence of SARS-CoV-2 reinfection: analysis of 35,000 subjects and overview of systematic reviews. [PDF]

Clin Exp Med, 2023
Pecoraro V, Pirotti T, Trenti T.
europepmc   +1 more source

Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021. [PDF]

Virol J, 2021
Lai A, Bergna A, Menzo S, Zehender G, Caucci S, Ghisetti V, Rizzo F, Maggi F, Cerutti F, Giurato G, Weisz A, Turchi C, Bruzzone B, Ceccherini Silberstein F, Clementi N, Callegaro A, Sagradi F, Francisci D, Venanzi Rullo E, Vicenti I, Clementi M, Galli M, collaborative group SCIRE SARS-CoV-2 Italian Research Enterprise.   +22 more
europepmc   +1 more source

Efficacy and Safety of Sotrovimab Versus Oral Antiviral for Early Treatment in High-Risk Patients in Omicron Era: A Multicenter Retrospective Study. [PDF]

Pathogens
Russo A, Pisaturo M, Cacace C, Troise A, Granata G, Grimaldi P, Allegorico E, Ambrisi F, Papillo M, Numis FG, Coppola N.   +10 more
europepmc   +1 more source

Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis.

JAMA Netw Open, 2023
Januel E, Hajage D, Labauge P, Maillart E, De Sèze J, Zephir H, Pelletier J, Guilloton L, Bensa C, Heinzlef O, Casez O, Biotti D, Bourre B, Vukusic S, Maurousset A, Berger E, Laplaud D, Lebrun-Frénay C, Dubessy AL, Branger P, Thouvenot E, Clavelou P, Sellal F, Manchon E, Moreau T, Papeix C, Tubach F, Louapre C.   +27 more
europepmc   +1 more source

Errori o varianti d'autore?

Il contributo offre una diversa interpretazione della tradizione manoscritta e a stampa del sonetto 35 di Garcilaso de la Vega, proponendo, sulla base del riesame delle varianti e della dimostrabile anteriorità del ms. Venezia Marciana It. IX, 137 rispetto alla princeps del 1574, di assumere i tre testimoni come redazioni d'autore in progress ...
openaire   +1 more source

Clinical and epidemiological factors causing longer SARS-CoV 2 viral shedding: the results from the CoviCamp cohort. [PDF]

Infection
Grimaldi P, Russo A, Pisaturo M, Maggi P, Allegorico E, Gentile I, Sangiovanni V, Rossomando A, Pacilio R, Calabria G, Pisapia R, Carriero C, Masullo A, Manzillo E, Russo G, Parrella R, Dell'Aquila G, Gambardella M, Ponticiello A, Onorato L, Coppola N, CoviCam group.   +21 more
europepmc   +1 more source

SCHEDA SEMINARIO IL MANOSCRITTO MODERNO. COME SI LEGGE, SI TRASCRIVE, SI RAPPRESENTA, SI PUBBLICA [PDF]

, 2017
Italia, Paola Maria Carmela
core  

Molecular and epigenetic markers as promising tools to quantify the effect of occupational exposures and the risk of developing non-communicable diseases. [PDF]

Med Lav, 2019
Ferrari L, Pavanello S, Bollati V.
europepmc   +1 more source